Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman - Een podcast door Timmerman Report
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
